Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Accounts Payables (2016 - 2025)

Mesa Laboratories' Accounts Payables history spans 15 years, with the latest figure at $5.3 million for Q4 2025.

  • For Q4 2025, Accounts Payables fell 8.6% year-over-year to $5.3 million; the TTM value through Dec 2025 reached $5.3 million, down 8.6%, while the annual FY2025 figure was $5.7 million, 4.87% down from the prior year.
  • Accounts Payables for Q4 2025 was $5.3 million at Mesa Laboratories, up from $5.1 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $7.9 million in Q1 2022 and bottomed at $4.0 million in Q2 2021.
  • The 5-year median for Accounts Payables is $5.7 million (2024), against an average of $5.9 million.
  • The largest annual shift saw Accounts Payables surged 140.98% in 2021 before it crashed 37.84% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $7.8 million in 2021, then dropped by 19.66% to $6.3 million in 2022, then fell by 27.58% to $4.6 million in 2023, then rose by 26.2% to $5.7 million in 2024, then fell by 8.6% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for MLAB's Accounts Payables are $5.3 million (Q4 2025), $5.1 million (Q3 2025), and $6.3 million (Q2 2025).